Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
902.15
10.60 (1.19%)
< Home < Back

Cadila Healthcare informs about loss of share certificate

Date: 18-02-2022

Pursuant to Regulation 39(3) of the SEBI Listing Regulations, Cadila Healthcare has informed that the company has received information of loss of share certificate and request for issue of duplicate share certificate as per the details are attached.

The above information is a part of company’s filings submitted to BSE.